Matthew Appleton
Image of Matthew Appleton
  • Grünenthal on multiple transactions, including its USD922m acquisition from AstraZeneca of prescription products Nexium in Europe and Vimovo worldwide (excluding the U.S. and Japan; its acquisition of the European rights to the prescription product Crestor from AstraZeneca for up to USD350m; and its acquisition of the global rights to the migraine medication, Zomig, from AstraZeneca for a total consideration of up to USD302m.
  • Life Healthcare on its GBP910m sale of Alliance Medical Group to iCON Infrastructure; and on its prior GBP600m acquisition of Alliance Medical Group by way of auction.
  • BTG on its GBP3.3bn takeover offer by Boston Scientific.
  • Haleon on its GBP235m divestment of Lamisil to Karo Healthcare; and its sale of Chapstick to Suave Brands, a portfolio company of Yellow Wood Partners, for an aggregate consideration of USD510m.
  • Kyowa Kirin International on its joint venture collaboration with Grünenthal in respect of KKI's established medicines portfolio.
  • Reckitt on various transactions including the sale of its E45 brand and related sub-brands to Karo Pharma for an implied enterprise value of GBP200m.
  • Castore, a leading premium performance sportswear brand and technology-enabled, end-to-end digital platform for global sports teams, on its GBP145m investment from The Raine Group, Hanaco Ventures and Felix Capital to fund future growth.
  • NNS Group on its investment into and acquisition of English Championship football club Aston Villa, alongside Wes Edens.
  • Tesco on the GBP181m sale of its Polish business to Salling Group and additional divestments of its Polish store estate.
  • SSL International on its recommended public takeover by Reckitt Benckiser for GBP2.54bn.
  • Tullett Prebon on its GPB1.4bn reverse takeover, carve-out acquisition of ICAP's global hybrid broking and information business and related issuance of consideration shares and readmission to the LSE.
  • TUI AG on its all-share merger with TUI Travel and related admission to the LSE.

    • Recognition

    “Pragmatic legal advice tailored to international environment with considerable industry expertise. Matthew Appleton is focusing specifically on what really matters for the business of his client far beyond legal expertise”
    Legal 500, UK, 2021 (M&A Upper Mid-Market and Premium Deals)

    Related articles

    Insights